Reuters logo
BRIEF-Revive Therapeutics and South Carolina Research Foundation enter into exclusive license agreement
September 19, 2017 / 11:21 AM / 3 months ago

BRIEF-Revive Therapeutics and South Carolina Research Foundation enter into exclusive license agreement

Sept 19 (Reuters) - Revive Therapeutics Ltd

* Revive Therapeutics and South Carolina Research Foundation enter into exclusive license agreement for cannabinoids-based therapeutics in the treatment of liver diseases

* Revive Therapeutics Ltd - ‍Revive will pay SCRF a nominal one time fee for entering into license​

* Revive Therapeutics Ltd - ‍future payments will be based on clinical trial and revenue milestones reached by Revive in future​

* Revive Therapeutics - will acquire exclusive license from SCRF to develop, commercialize portfolio of patents based on cannabinoid-based therapeutics​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below